Serum granulysin is a marker for Th1 type immunity in pre-eclampsia

Area of Science:

• Immunology
• Obstetrics
• Biochemistry

Background:

• Pre-eclampsia is linked to a Th1 predominant immune state, suggesting a breakdown in immune tolerance.
• Granulysin, a cytotoxic protein from NK cells and CTLs, is crucial in cell-mediated immunity.
• Previous work established an ELISA for serum granulysin as a marker for cell-mediated immunity.

Purpose of the Study:

• To investigate serum granulysin levels in pre-eclamptic patients.
• To assess the correlation between serum granulysin and clinical/immunological parameters in pre-eclampsia.
• To evaluate granulysin as a potential biomarker for Th1/Th2 balance in pre-eclampsia.

Main Methods:

• Developed and utilized an enzyme-linked immunosorbent assay (ELISA) to measure serum granulysin.
• Compared serum granulysin levels between pre-eclamptic patients and normal pregnancy subjects.
• Analyzed associations between serum granulysin levels and mean blood pressure, Th1 cell percentages, and Th1/Th2 ratios.

Main Results:

• Serum granulysin levels were significantly higher in pre-eclamptic patients compared to normal pregnancies.
• Elevated serum granulysin correlated with increased mean blood pressure and higher percentages of peripheral blood Th1 cells.
• A strong association was observed between serum granulysin levels and Th1/Th2 ratios in pre-eclamptic individuals.

Conclusions:

• Serum granulysin is significantly elevated in pre-eclampsia.
• Granulysin serves as a potential novel biomarker for evaluating Th1-type immunity and Th1/Th2 balance in pre-eclampsia.
• These findings highlight the role of cell-mediated immunity in the pathophysiology of pre-eclampsia.